{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-019059","form_type":"8-K","ticker":"BLGO","cik":"0000880242","company_name":"BIOLARGO, INC.","filed_at":"2022-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.410227+00:00","generated_at":"2026-06-24T03:33:09.301210+00:00","sec_items":["7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"BioLargo Q2 2022 revenue ~$1.3M, up 185% YoY; preliminary figures","bullets":["Q2 revenue ~$1.3M, up 37% sequentially and 185% vs Q2 2021.","Growth driven by POOPH retail launch, PFAS treatment tech, waste-to-energy project.","National nuclear fuel innovator prototype project expected to expand after successful Phase 1.","Full Q2 results due in Form 10-Q by Aug 15, 2022; figures preliminary and unaudited.","Company plans investor webcast shortly after 10-Q filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-019059","json":"https://secwatch.observer/filing/0001437749-22-019059.json","markdown":"https://secwatch.observer/filing/0001437749-22-019059.md","text":"https://secwatch.observer/filing/0001437749-22-019059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/880242/000143774922019059/0001437749-22-019059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/880242/000143774922019059/blgo20220804_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T03:33:09.301210+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}